loratadine has been researched along with piperidines in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (8.20) | 18.7374 |
1990's | 19 (31.15) | 18.2507 |
2000's | 30 (49.18) | 29.6817 |
2010's | 7 (11.48) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Affrime, MB; Billah, MM; Brannan, MD; Christopher, JD; Eckel, SP; Gilchrest, HG; Granzow, CA; Lawton, PJ; Radwanski, E; Richards, W | 1 |
Billah, MM; Chapman, RW; Egan, RW; Kreutner, W; Siegel, MI; Watnick, AS | 1 |
Billah, MM; Egan, RW; Ganguly, AK; Green, MJ; Kreutner, W; Piwinski, JJ; Siegel, MI; Villani, FJ; Wong, JK | 1 |
Halstenson, CE; Hilbert, J; Matzke, GR; Opsahl, JA; Perentesis, G; Radwanski, E; Zampaglione, N | 1 |
Billah, MM; Chapman, RW; Egan, RW; Gilchrest, H; Kreutner, W; Piwinski, JJ; Sherwood, J; Siegel, MI; West, RE | 1 |
Ahn, HS; Barnett, A | 1 |
Barnett, A; Cohen-Winston, M; Iorio, LC | 1 |
Gural, RP; Herron, J; Kassem, N; Roman, IJ | 1 |
Affrime, MB; Hilbert, J; Perentesis, G; Radwanski, E; Symchowicz, S; Zampaglione, N | 1 |
Ahn, HS; Barnett, A; Gulbenkian, A; Iorio, LC; Kreutner, W; Tozzi, S | 1 |
Bolser, DC; Chapman, RW; DeGennaro, FC; Hey, JA; O'Reilly, S | 1 |
Bousquet, J; Campbell, AM; Crampette, L; Czarlewski, W; Mondain, M; Sauvère, G; Vignola, AM | 1 |
O'Hanlon, JF; Ramaekers, JG | 1 |
Bahmer, FA | 1 |
Blume, H; Zhong, D | 1 |
Christensen, J; Johnson, R; Lin, CC | 1 |
Cayen, MN; Chen, KJ; Clement, RP; Huie, K; Snow, M; Yumibe, N | 1 |
Ducic, I; Ko, CM; Morad, M; Shuba, Y | 1 |
Caballero, R; Delpón, E; Franqueza, L; Longobardo, M; Tamargo, J; Valenzuela, C | 1 |
Centemeri, C; Ciceri, P; Colli, S; Nicosia, S; Tosarello, D | 1 |
Mattila, MJ; Paakkari, I | 1 |
Danielson, L; DeVos, C; Grant, JA; Rihoux, JP | 1 |
Billah, MM; Carruthers, NI; Chan, TM; Kaminski, JJ; McPhail, AT; Tozzi, S; Wong, SC | 1 |
Abdelaziz, MM; Devalia, JL; Khair, OA | 1 |
Georges, GC; Lim, JC; Ratner, PH | 1 |
Górska, M; Grzelewska-Rzymowska, I; Pietrzkowicz, M | 1 |
DeVos, C; Grant, JA; Moulaert, B; Riethuisen, JM | 1 |
Fridliand, DG; Gushchin, IS; Poroshina, IuA; Shul'zhenko, AE | 1 |
Burri, P; Karppinen, A; Kautiainen, H; Petman, L; Reunala, T | 1 |
Paakkari, I | 1 |
Antonijoan, R; Barbanoj, M; Esbrí, R; Garcia, E; Gich, I; Gispert, J; Luria, X | 1 |
Amad, M; Mylchreest, I; Rudewicz, PJ; Schoen, AE; Schweingruber, H; Winnik, WM; Yang, L | 1 |
Gras, J; Llenas, J; Llupià, J | 1 |
Gispert, J; Hampel, F; Ratner, P | 1 |
Boyce, M; Carey, W; Luria, X; Warrington, S | 1 |
Chen, XY; Dong, YM; Zhang, YF; Zhong, DF | 1 |
Alcántar, F; Herrera, J; Morales, JM; Rodríguez, JM; Rosete, R; Villacampa, J | 1 |
Appajosyula, S; Gelfand, EW; Meeves, S | 1 |
Hampel, F; Howland, W; Ratner, P; Van Bavel, J | 2 |
Naidong, W; Song, Q; Zhou, S; Zhou, W | 1 |
Chaikin, P; Gillen, MS; Malik, M; Pentikis, H; Rhodes, GR; Roberts, DJ | 1 |
Chuecos, F; Esbrí, R; Falqués, M; Gispert, J; Luria, X; Peris, F; Ratner, P; Rosales, MJ | 1 |
David, V; Medvedovici, A; Sora, DI; Udrescu, S | 1 |
Antonijoan, RM; Barbanoj, MJ; Esbri, R; Fortea, J; García-Gea, C; Puntes, M; Valle, M | 1 |
Antonijoan, R; Barbanoj, MJ; Esbrí, R; Fortea, J; García-Gea, C; Pérez, J; Puntes, M; Serra, C | 1 |
Calmels, T; Leppaenen, J; Mach, UR; Sasse, BC; Stark, H | 1 |
Devillier, P | 1 |
Apostolou, C; Dotsikas, Y; Kousoulos, C; Loukas, YL | 1 |
Bachert, C; Dimitrov, V; Gorina, MM; Ivan, P; Kuna, P; Loureiro, A; Sanquer, F; van de Heyning, P | 1 |
Ikezawa, Z; Inomata, N; Tatewaki, S | 1 |
Patel, BN; Sanyal, M; Sharma, N; Shrivastav, PS | 1 |
Conrad, DH; Lichtman, AH; O'Neal, ST; Schlosburg, JE | 1 |
Bindslev-Jensen, C; Doyle, E; Maurer, M; Metz, M; Watanabe, T; Zuberbier, T | 1 |
Carter, NJ | 1 |
Plichta, D; Spiewak, R | 1 |
da Silva, J; Dos Santos, K; Locks, RB | 1 |
Antonijoan, R; Campo, C; Coimbra, J; García-Gea, C; Gich, I; Labeaga, L; Puntes, M; Valiente, R | 1 |
8 review(s) available for loratadine and piperidines
Article | Year |
---|---|
Topical levocabastine--an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis.
Topics: Administration, Oral; Administration, Topical; Clinical Trials as Topic; Conjunctivitis, Allergic; Double-Blind Method; Histamine H1 Antagonists; Humans; Loratadine; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Seasonal; Terfenadine | 1995 |
Variations among non-sedating antihistamines: are there real differences?
Topics: Astemizole; Benzimidazoles; Butyrophenones; Central Nervous System; Cetirizine; Drug Interactions; Heart; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Loratadine; Piperidines; Potassium Channel Blockers; Terfenadine; Triprolidine | 1999 |
[The effect of second generation histamine antagonists on the heart].
Topics: Animals; Area Under Curve; Astemizole; Butyrophenones; Electrocardiography; Heart; Histamine H1 Antagonists; Humans; Loratadine; Piperidines; Tachycardia; Terfenadine; Torsades de Pointes | 2001 |
Cardiotoxicity of new antihistamines and cisapride.
Topics: Arrhythmias, Cardiac; Astemizole; Benzimidazoles; Butyrophenones; Cetirizine; Cisapride; Heart Diseases; Histamine H1 Antagonists; Humans; Loratadine; Piperidines; Serotonin Receptor Agonists; Terfenadine; Triprolidine | 2002 |
Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research.
Topics: Animals; Anti-Inflammatory Agents; Butyrophenones; Cells, Cultured; Histamine H1 Antagonists; Loratadine; Piperidines; Terfenadine | 2004 |
Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
Topics: Adult; Butyrophenones; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Multicenter Studies as Topic; Piperidines; Placebos; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Seasonal | 2005 |
Bilastine: in allergic rhinitis and urticaria.
Topics: Area Under Curve; Benzimidazoles; Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Urticaria | 2012 |
[Pharmacotherapy of urticaria--an analysis of the discrepancies between guidelines of expert bodies, registration documents and evidence for the effectiveness of drugs].
Topics: Administration, Oral; Administration, Topical; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Glucocorticoids; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperidines; Poland; Practice Guidelines as Topic; Terfenadine; Treatment Outcome; Urticaria | 2013 |
20 trial(s) available for loratadine and piperidines
Article | Year |
---|---|
Differential plasma duration of antiplatelet-activating factor and antihistamine activities of oral Sch 37370 in humans.
Topics: Administration, Oral; Adult; Double-Blind Method; Electrocardiography; Histamine Antagonists; Humans; Loratadine; Male; Piperidines; Platelet Activating Factor | 1992 |
Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man.
Topics: Adolescent; Adult; Chlorpheniramine; Dose-Response Relationship, Drug; Histamine; Histamine Antagonists; Humans; Loratadine; Male; Piperidines; Skin; Tachyphylaxis; Time Factors | 1986 |
Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aerosols; Aged; Conjunctivitis, Allergic; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Ophthalmic Solutions; Piperidines; Rhinitis, Allergic, Seasonal | 1994 |
Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.
Topics: Automobile Driving; Benzimidazoles; Butyrophenones; Cetirizine; Clemastine; Diphenhydramine; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Humans; Loratadine; Netherlands; Piperidines; Psychomotor Performance; Terfenadine; Triprolidine | 1995 |
A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
Topics: Adult; Butyrophenones; Cetirizine; Cross-Over Studies; Dibenzazepines; Double-Blind Method; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Imidazoles; Loratadine; Male; Piperidines; Skin Tests; Terfenadine; Urticaria | 1999 |
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
Topics: Adolescent; Adult; Aged; Butyrophenones; Child; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Piperidines; Rhinitis, Allergic, Seasonal | 2000 |
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Topics: Adult; Benzimidazoles; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Piperidines; Terfenadine; Treatment Outcome; Urticaria | 2002 |
Comparison of cetirizine, ebastine and loratadine in the treatment of immediate mosquito-bite allergy.
Topics: Adult; Animals; Butyrophenones; Cetirizine; Conscious Sedation; Cross-Over Studies; Culicidae; Double-Blind Method; Finland; Histamine H1 Antagonists; Humans; Hypersensitivity, Immediate; Insect Bites and Stings; Loratadine; Middle Aged; Piperidines; Pruritus; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
Topics: Adolescent; Adult; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Kinetics; Loratadine; Male; Middle Aged; Piperidines; Skin Tests | 2002 |
Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis.
Topics: Adult; Ambrosia; Butyrophenones; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Nasal Obstruction; Piperidines; Rhinitis, Allergic, Seasonal | 2003 |
Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
Topics: Adolescent; Adult; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Hypersensitivity, Immediate; Injections, Intradermal; Loratadine; Male; Piperidines; Skin Tests; Terfenadine | 2002 |
Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects.
Topics: Administration, Oral; Adult; Antipruritics; Area Under Curve; Asian People; Humans; Loratadine; Male; Piperidines; Pyridines | 2003 |
Pharmacokinetic properties of single-dose loratadine and ambroxol alone and combined in tablet formulations in healthy men.
Topics: Administration, Oral; Adolescent; Adult; Ambroxol; Area Under Curve; Cross-Over Studies; Drug Combinations; Expectorants; Histamine Antagonists; Humans; Loratadine; Male; Middle Aged; Piperidines; Pyridines; Tablets; Time Factors | 2003 |
Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Butyrophenones; Child; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Least-Squares Analysis; Loratadine; Male; Middle Aged; Piperidines; Rhinitis, Allergic, Seasonal | 2004 |
A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
Topics: Administration, Oral; Butyrophenones; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Loratadine; Male; Multivariate Analysis; Patch Tests; Piperidines; Probability; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Treatment Outcome | 2004 |
Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
Topics: Adolescent; Adult; Antifungal Agents; Butyrophenones; Double-Blind Method; Drug Combinations; Electrocardiography; Heart Rate; Histamine H1 Antagonists; Humans; Ketoconazole; Loratadine; Male; Piperidines | 2005 |
A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
Topics: Adult; Butyrophenones; Chemistry, Pharmaceutical; Dermatitis, Contact; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Pain Measurement; Patient Acceptance of Health Care; Piperidines; Skin; Tablets; Treatment Outcome | 2007 |
Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adult
Topics: Adolescent; Adult; Butyrophenones; Cross-Over Studies; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Male; Pain Measurement; Piperidines; Pruritus; Skin; Skin Tests | 2007 |
Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
Topics: Adolescent; Adult; Aged; Area Under Curve; Benzimidazoles; Child; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Loratadine; Male; Middle Aged; Piperidines; Quality of Life; Rhinitis, Allergic, Seasonal; Treatment Outcome; Young Adult | 2009 |
Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.
Topics: Adult; Benzimidazoles; Cross-Over Studies; Cyproheptadine; Double-Blind Method; Female; Healthy Volunteers; Histamine; Histamine Antagonists; Humans; Injections, Intradermal; Loratadine; Male; Piperidines; Skin | 2017 |
33 other study(ies) available for loratadine and piperidines
Article | Year |
---|---|
Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine.
Topics: Animals; Antigens; Bronchial Spasm; Guinea Pigs; Histamine Antagonists; Humans; Hyperventilation; Loratadine; Male; Piperidines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Lew | 1991 |
Discovery and preliminary pharmacology of Sch 37370, a dual antagonist of PAF and histamine.
Topics: Histamine Antagonists; Humans; Kinetics; Loratadine; Male; Piperidines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship | 1991 |
Pharmacokinetics of loratadine in patients with renal insufficiency.
Topics: Adult; Cyproheptadine; Female; Humans; Kidney Failure, Chronic; Loratadine; Male; Middle Aged; Piperidines; Pyridines; Renal Dialysis; Time Factors | 1990 |
Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
Topics: Administration, Oral; Animals; Binding, Competitive; Brain; Bronchial Spasm; Female; Guinea Pigs; Histamine; Histamine Antagonists; Humans; Loratadine; Lung; Macaca fascicularis; Male; Mice; Piperidines; Platelet Activating Factor; Platelet Aggregation; Pyrilamine; Rats | 1990 |
Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine.
Topics: Aminopyridines; Animals; Binding, Competitive; Cerebral Cortex; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Kinetics; Loratadine; Lung; Male; Piperidines; Pyrilamine; Receptors, Cell Surface | 1986 |
Interaction studies in mice of SCH 29851, a potential non-sedating antihistamine, with commonly used therapeutic agents.
Topics: Animals; Benzhydryl Compounds; Diphenhydramine; Dose-Response Relationship, Drug; Electroshock; Hexobarbital; Histamine Antagonists; Loratadine; Male; Mice; Motor Activity; Piperidines; Reflex; Seizures; Stereotyped Behavior; Terfenadine; Vocalization, Animal | 1986 |
Excretion of loratadine in human breast milk.
Topics: Adult; Cyproheptadine; Female; Histamine Antagonists; Humans; Loratadine; Milk, Human; Piperidines; Pyridines | 1988 |
Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine.
Topics: Animals; Anticonvulsants; Autonomic Nervous System; Behavior, Animal; Binding, Competitive; Cerebral Cortex; Dioxanes; Dogs; Female; Guinea Pigs; Histamine; Histamine Antagonists; Hypnotics and Sedatives; Lethal Dose 50; Loratadine; Male; Mice; Physostigmine; Piperidines; Pyrilamine; Rats; Saimiri; Time Factors | 1984 |
Pharmacological studies of allergic cough in the guinea pig.
Topics: Administration, Oral; Aerosols; Albuterol; Analysis of Variance; Animals; Antitussive Agents; Capsaicin; Chlorpheniramine; Cimetidine; Codeine; Cough; Drug Hypersensitivity; Guinea Pigs; Hexamethonium; Histamine Antagonists; Indomethacin; Injections, Subcutaneous; Ipratropium; Loratadine; Male; Ovalbumin; Piperidines; Receptors, Histamine H1; Receptors, Histamine H2 | 1995 |
Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells.
Topics: Adult; Histamine; Histamine H1 Antagonists; HLA-DR Antigens; Humans; In Vitro Techniques; Intercellular Adhesion Molecule-1; Loratadine; Middle Aged; Nasal Mucosa; Nasal Polyps; Piperidines; Pyridines; Turbinates | 1995 |
[HPLC-determination of loratadine and its active metabolite descarboethoxyloratadine in human plasma].
Topics: Chromatography, High Pressure Liquid; Humans; Loratadine; Piperidines; Pyridines; Spectrometry, Fluorescence | 1994 |
Sensitive gas-liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine, in human plasma using a nitrogen-phosphorus detector.
Topics: Child; Chromatography, Gas; Female; Humans; Hydrogen-Ion Concentration; Loratadine; Male; Nitrogen; Phosphorus; Piperidines; Pyridines; Sensitivity and Specificity | 1994 |
Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Binding Sites; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Histamine H1 Antagonists; Humans; In Vitro Techniques; Ketoconazole; Loratadine; Microsomes, Liver; Mixed Function Oxygenases; Models, Molecular; Oxidation-Reduction; Piperidines; Pyridines; Quinidine; Recombinant Proteins; Substrate Specificity; Troleandomycin | 1996 |
Comparative effects of loratadine and terfenadine on cardiac K+ channels.
Topics: Animals; Cation Transport Proteins; Ether-A-Go-Go Potassium Channels; Gene Expression; Guinea Pigs; Heart Ventricles; Histamine H1 Antagonists; In Vitro Techniques; Loratadine; Male; Membrane Potentials; Myocardium; Oocytes; Patch-Clamp Techniques; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Wistar; Recombinant Proteins; Terfenadine; Xenopus laevis | 1997 |
Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.
Topics: Animals; Cell Line; Dose-Response Relationship, Drug; Heart Ventricles; Humans; Ion Channel Gating; Kv1.5 Potassium Channel; Loratadine; Membrane Potentials; Mice; Patch-Clamp Techniques; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines | 1997 |
Heterogeneous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophages.
Topics: Animals; Azepines; Blood Platelets; Calcium; Cytosol; Humans; Loratadine; Macrophages; Male; Piperidines; Platelet Membrane Glycoproteins; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles | 1999 |
Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine.
Topics: Animals; Anti-Allergic Agents; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Guinea Pigs; Histamine Antagonists; Humans; Inhibitory Concentration 50; Isoquinolines; Loratadine; Mice; Models, Molecular; Molecular Conformation; Molecular Mimicry; Piperazines; Piperidines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rats; Receptors, Histamine H1; Stereoisomerism; Structure-Activity Relationship | 1999 |
The potential of active metabolites of antihistamines in the management of allergic disease.
Topics: Anti-Inflammatory Agents; Butyrophenones; Cells, Cultured; Cetirizine; Chymases; Eosinophils; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Histamine; Histamine H1 Antagonists; Humans; Hypersensitivity; Intercellular Adhesion Molecule-1; Interleukin-3; Interleukin-8; Loratadine; Mast Cells; Piperidines; Potassium Channel Blockers; Potassium Channels; Prostaglandin D2; Pyridines; Recombinant Fusion Proteins; Recombinant Proteins; Serine Endopeptidases; Terfenadine; Time Factors; Tryptases | 2000 |
[Comparative antihistamine and anti-allergic effects of various antihistamine preparations].
Topics: Adult; Anti-Allergic Agents; Butyrophenones; Cetirizine; Clemastine; Female; Histamine H1 Antagonists; Humans; Hypersensitivity; Loratadine; Male; Piperidines; Pollen; Terfenadine | 2002 |
Investigation of an enhanced resolution triple quadrupole mass spectrometer for high-throughput liquid chromatography/tandem mass spectrometry assays.
Topics: Calibration; Chromatography, High Pressure Liquid; Loratadine; Mometasone Furoate; Pharmaceutical Preparations; Piperidines; Pregnadienediols; Pyridines; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2002 |
Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Topics: Aerosols; Airway Resistance; Algorithms; Animals; Anti-Allergic Agents; Bronchial Spasm; Butyrophenones; Cetirizine; Guinea Pigs; Histamine; Histamine H1 Antagonists; Leukotriene C4; Loratadine; Male; Ovalbumin; Piperidines | 2003 |
[Antihistaminics. Side effects also after raising dosage at the placebo level].
Topics: Anti-Allergic Agents; Benzimidazoles; Butyrophenones; Cetirizine; Double-Blind Method; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Meta-Analysis as Topic; Piperidines; Placebos; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 2003 |
[In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
Topics: Anti-Allergic Agents; Butyrophenones; Cetirizine; Double-Blind Method; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Multicenter Studies as Topic; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Time Factors | 2003 |
Direct injection of 96-well organic extracts onto a hydrophilic interaction chromatography/tandem mass spectrometry system using a silica stationary phase and an aqueous/organic mobile phase.
Topics: Chromatography, Liquid; Humans; Loratadine; Omeprazole; Pharmaceutical Preparations; Piperidines; Protease Inhibitors; Pyridines; Reserpine; Spectrometry, Mass, Electrospray Ionization | 2004 |
Validated ion pair liquid chromatography/fluorescence detection method for assessing the variability of the loratadine metabolism occurring in bioequivalence studies.
Topics: Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Drug Stability; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Molecular Structure; Piperidines; Pyridines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Therapeutic Equivalency | 2007 |
Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
Topics: Amines; Animals; Binding, Competitive; Cell Line; Cetirizine; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; Drug Design; Drug Evaluation, Preclinical; Histamine H1 Antagonists; Humans; Ketotifen; Ligands; Loratadine; Mianserin; Molecular Structure; Piperidines; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship | 2007 |
Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet [20 mg] versus desloratadine capsule [5 mg]: a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adult
Topics: Butyrophenones; Histamine; Histamine H1 Antagonists; Humans; Loratadine; Piperidines; Randomized Controlled Trials as Topic; Skin Tests | 2007 |
Comparison of hydrophilic interaction and reversed-phase liquid chromatography coupled with tandem mass spectrometric detection for the determination of three pharmaceuticals in human plasma.
Topics: Cetirizine; Chromatography, Liquid; Donepezil; Humans; Indans; Loratadine; Piperidines; Reproducibility of Results; Tandem Mass Spectrometry | 2008 |
Multiple H1-antihistamine-induced urticaria.
Topics: Administration, Oral; Adult; Drug Eruptions; Female; Histamine; Histamine H1 Antagonists; Humans; Immunologic Tests; Leukotriene B4; Loratadine; Piperidines; Pyridines; Skin Tests; Terfenadine; Urticaria | 2009 |
LC-MS-ESI for the determination of loratadine and descarboethoxyloratadine in human plasma.
Topics: Chromatography, Liquid; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Piperidines; Pyridines; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Time Factors | 2010 |
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Female; Histamine H1 Antagonists; Hypersensitivity; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Loratadine; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Pain; Piperidines; Pruritus; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2011 |
Effects of antihistamines on innate immune responses to severe bacterial infection in mice.
Topics: Animals; Anti-Allergic Agents; Bacterial Infections; Diphenhydramine; Histamine Antagonists; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Histamine H3 Antagonists; Humans; Immunity, Innate; Loratadine; Mice; Mice, Inbred C57BL; Peritonitis; Piperidines; Receptors, Histamine; Sepsis | 2011 |
Quality of life in patients with allergic rhinitis: a clinical trial comparing the use of bilastine versus loratadine.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Brazil; Double-Blind Method; Female; Humans; Loratadine; Male; Middle Aged; Piperidines; Prospective Studies; Quality of Life; Rhinitis, Allergic; Treatment Outcome | 2017 |